Compare OLB & ACON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | OLB | ACON |
|---|---|---|
| Founded | 1993 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Retail: Computer Software & Peripheral Equipment |
| Sector | Technology | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.4M | 7.5M |
| IPO Year | 2019 | 2022 |
| Metric | OLB | ACON |
|---|---|---|
| Price | $0.19 | $2.34 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 7.1M | 40.3K |
| Earning Date | 11-13-2026 | 11-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 71.48 | ★ 99.82 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $8,676,907.00 | $75,730.00 |
| Revenue This Year | N/A | $78.26 |
| Revenue Next Year | N/A | $90.37 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 65.62 |
| 52 Week Low | $0.18 | $1.95 |
| 52 Week High | $1.80 | $12.03 |
| Indicator | OLB | ACON |
|---|---|---|
| Relative Strength Index (RSI) | 32.84 | 43.70 |
| Support Level | $0.18 | $2.33 |
| Resistance Level | $0.34 | $2.50 |
| Average True Range (ATR) | 0.02 | 0.18 |
| MACD | -0.00 | -0.02 |
| Stochastic Oscillator | 10.59 | 4.35 |
The OLB Group Inc is a diversified FinTech company that focuses on a suite of products in the merchant services marketplace and seeks to provide integrated business solutions to merchants throughout the United States. The company seeks to provide merchants with a wide range-of-products and services through the various online platforms, including financial and transaction processing services. It also has products that provide support for crowdfunding and other capital-raising initiatives. It supplements the online platforms with certain hardware solutions that are integrated with the online platforms. The company has two business segments: Fintech Services, which generates key revenue, and the Bitcoin Mining business segment.
Aclarion Inc is a healthcare technology company that leverages Magnetic Resonance Spectroscopy (MRS), proprietary signal processing techniques, biomarkers, and augmented intelligence algorithms to optimize clinical treatments. The Company is first addressing the chronic low back pain market with Nociscan. Through a cloud connection, Nociscan receives magnetic resonance spectroscopy (MRS) data from an MRI machine for each lumbar disc being evaluated. In the cloud, proprietary signal processing techniques extract and quantify chemical biomarkers demonstrated to be associated with disc pain. When used with other diagnostic tools, Nociscan provides critical insights into the location of a patient's low back pain, giving physicians clarity to optimize treatment strategies.